Sequence variants of the Axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding

Genes Chromosomes and Cancer

Volumn 28, Issue 4, 2000, Pages 443-453

  Webster, Marie Therese ^a   Rozycka, Magdalena ^a   Sara, Elizabeth ^a   Davis, Elaine ^a   Smalley, Matthew ^a   Young, Neville ^a   Dale, Trevor C ^a   Wooster, Richard ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; TRANSCRIPTION FACTOR;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COLONIC NEOPLASMS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; LEUCINE; MALE; METHIONINE; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; OVARIAN NEOPLASMS; PROTEIN BINDING; PROTEINS; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

MAMMALIA;

EID: 0033948526     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(200008)28:4<443::AID-GCC10>3.0.CO;2-D     Document Type: Article

References (44)

1. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. 1997. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
2. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W. 1998. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280:596-599.
3. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M. 1994. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 91:6319-6323.
4. Bienz M. 1998. TCF: Transcriptional activator or repressor? Cur Opin Cell Biol 10:366-372.
5. Chen TR, Dorotinsky CS, McGuire LJ, Macy ML, Hay RJ. 1995. DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin. Cancer Genet Cytogenet 81:103-108.
6. Collins N, Wooster R, Stratton MR. 1997. Absence of methylation of CpG dinucleotides within the promotor of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br J Cancer 76:1150-1156.
7. Fagotto F, Jho E, Zeng L, Kurth T, Joos T, Kaufmann C, Costantini F. 1999. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol 145:741-756.
8. Hamada F, Tomoyasu Y, Takatsu Y, Nakamura M, Nagai S, Suzuki A, Fujita F, Shibuya H, Toyoshima K, Ueno N, Akiyama T. 1999. Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin. Science 283:1739-1742.
9. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. 1998. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8:573-581.
10. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
11. Hedgepeth CM, Deardorff MA, Klein PS. 1999a. Xenopus axin interacts with glycogen synthase kinase-3 beta and is expressed in the anterior midbrain. Mech Dev 80:147-151.
12. Hedgepeth CM, Deardorff MA, Rankin K, Klein PS. 1999b. Regulation ofglycogen synthase kinase 3beta and downstream Wnt signaling by Axin. Mol Cell Biol 19:7147-7157.
13. Homfray TF, Cottrell SE, Ilyas M, Rowan A, Talbot IC, Bodmer WF, Tomlinson IP. 1998. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumors. Hum Mutat 11:114-120.
14. Horii AS, Nakatsuru Y, Miyoshi S, Ichii H, Nagase H, Ando A, Yanagisawa E, Tsuchiya Y. 1992. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 52:6696-6698.
15. Hsu W, Zeng L, Costantini F. 1999. Identification of a domain of axin that binds to the serine/threonine protein phosphatase 2A and a self binding domain. J Biol Chem 273:3439-3445.
16. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. 1998. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK3 beta and beta-catenin and promotes GSK3 beta-dependent phosphorylation of beta-catenin. EMBO J 17:1371-1384.
17. Itoh K, Krupnik VE, Sokol SY. 1998. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 8:591-594.
18. Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A. 1997. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. EMBO J 16:441-450.
19. Jonkers J, van Amerongen R, van der Valk M, Robanus-Maandag E, Molenaar M, Destree O, Berns A. 1999a. In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3. Mech Dev 88:183-194.
20. Jonkers J, Weening JJ, der Valk M, Bobeldijk R, Berns A. 1999b. Overexpression of frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of frat1 in lymphoma progression. Oncogene 18:5982-5990.
21. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A. 1998. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273:10823-10826.
22. Kishida S, Yamamoto H, Hino S, Ikeda S, Kishida M, Kikuchi A. 1999. DIX domains of dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol 19:4414-4422.
23. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 275:1784-1787.
24. Li L, Yuan H, Weaver CD, Mao J, Farr GH Sussman DJ, Jonkers J, Kimelman D, Wu D. 1999. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LFF-1. EMBO J 18:4233-4240.
25. Mai M, Qian C, Yokomizo A, Smith DI, Liu W. 1999. Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24. Genomics 55:341-344.
26. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin of APC. Science 275:1787-1790.
27. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. 1997. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272:24735-24738.
28. Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palombo F, D'Arrigo A, Markowitz S, Willson JK, Kinzler KW, et al. 1995. Mutations of GTBP in genetically unstable cells. Science 268:1915-1917.
29. Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. 1995. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene 11:1319-1326.
30. Polakis P. 1999. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 9:15-21.
31. Sakanaka C, Weiss JB, Williams LT. 1998. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci USA 95: 3020-3023.
32. Sanz-Ortega J, Bryant B, Sanz-Esponera J, Asenjo JA, Saez MC, Torres A, Balibrea JL, Sobel ME, Merino MJ. 1999. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer. Pathol Res Pract 195:677-680.
33. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527.
34. Smalley MJ, Dale TC. 1999. Wnt Signalling in mammalian development and tumorigenesis. Cancer Met Rev 18:215-230.
35. Smalley MJ, Sara E, Paterson H, Naylor S, Cook D, Jayatilake H, Fryer LG, Hutchinson L, Fry MJ, Dale TC. 1999. Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J 18:2823-2835.
36. Thomas GM, Frame S, Goedert M, Nathke I, Polakis P, Cohen P. 1999. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of Axin and beta-catenin. FEBS Lett 458:247-251.
37. Vermeulen SJ, Nollet F, Teugels E, Philippe J, Speleman F, van Rov FM, Bracke ME, Mareel MM. 1997. Mutation of alpha-catenin results in invasiveness of human HCT-8 colon cancer cells. Ann NY Acad Sci 833:186-189.
38. Vermeulen SJ, Chen TR, Speleman F, Nollet F, Van Roy FM, Mareel MM. 1998. Did the four human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient? Cancer Genet Cytogenet 107:76-79.
39. Vermeulen SJ, Nollet F, Teugels E, Vennekens KM, Malfait F, Philippe J, Speleman F, Bracke ME, van Roy FM, Mareel MM. 1999. The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene 18:905-913.
40. Willert K, Logan CY, Arora A, Fish M, Nusse R. 1999. A drosophila axin homolog, daxin, inhibits wnt signaling. Development 126: 4165-4173.
41. Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M, Kikuchi A. 1998. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol 18:2867-2875.
42. Yost C, Torres M, Miller JR, Huang E, Kimelman D, Moon RT. 1996 The axis-inducing activity, stablity and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10:1443-1454.
43. Yost C, Farr GH, Pierce SB, Ferkey DM, Mingzi Chen M, Kimelman D. 1998. GBP, and Inhibitor of GSK3, is implicated in Xenopus development and oncogenesis. Cell 93:1031-1041.
44. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F. 1997. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90:181-192.